🟢 98/100

This product looks safe

  • N-Phenethyl Dimethylamine Citrate: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
  • 40% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ N-Phenethyl Dimethylamine Citrate: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)

Label Data

20.2 Gram(s) Serving Size
40 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Carbohydrates
2 Gram(s) (1% DV)
32 mg (200% DV)
✅ 2.3× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 32mg UL 35mg
50 mg (2942% DV)
📊 38.5× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 50mg UL 100mg
500 mcg (20834% DV)
📊 208.3× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.5mg
50 mg (12% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 50mg
Sodium
380 mg (16% DV)
Potassium
380 mg (8% DV)
13500 mg
📊 Market median: 500.0mg (223 products) 📚 22 studies (Tier A: 0, B: 1)
This product: 13500mg
L-Citruline
8000 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 4000mg
Malic Acid
3000 mg
Pink Himalayan Sea Salt
1000 mg
Synaptrix
1000 mg
✅ 1.5× RDA — within safe limits 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 800mg UL 3500mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 350 mg)
RDA 420mg This product: 500mg UL 350mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 400mg UL 400mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 200mg UL 400mg
Rauwolscine
1500 mcg
400 mcg
📊 Market median: 0.15mg (41 products)
Median 0.15mg This product: 0.4mg

Other Ingredients

Natural & Artificial Flavors Citric Acid Calcium Silicate Silicon Dioxide Sucralose Malic Acid Acesulfame Potassium Blue Spirulina

Label Claims — Verification

Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

🧪 Formulation Notes

High-stim pre-workout formula Intense focus Increased power & endurance Extreme energy

Blue Raspberry Naturally & artificially flavored

Product Details

DSLD Entry Date 2025-05-21
Product Type Other Combinations
Form Powder
Brand Gorilla Mind
DSLD ID 331655
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →